Cargando…
Commentary: Targeted high-risk screening for diabetic retinopathy in India: Feasible short-term strategy
Autores principales: | Agarwal, Divya, Kumar, Aman, Kumar, Atul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725084/ https://www.ncbi.nlm.nih.gov/pubmed/34708763 http://dx.doi.org/10.4103/ijo.IJO_2556_21 |
Ejemplares similares
-
Commentary: Training optometrists and allied ophthalmic personnel: Expanding horizon of diabetic retinopathy screening in India
por: Agarwal, Divya, et al.
Publicado: (2021) -
Commentary: Understanding diabetic retinopathy trends in India: Lessons learnt and future implications
por: Agarwal, Divya, et al.
Publicado: (2021) -
Commentary: Use of biosimilars for retinal diseases in India: Challenges and concerns
por: Kumar, Aman, et al.
Publicado: (2021) -
Diabetic retinopathy screening and management in India: Challenges and possible solutions
por: Kumar, Atul, et al.
Publicado: (2021) -
Commentary: Teleophthalmology in India: Hybrid approach will be a game changer in the COVID-19 Era
por: Agarwal, Divya, et al.
Publicado: (2021)